Nice article purporting what I have been hammering on about on another stock thread for a while now. The regulatory back drop for MSB has vastly improved with increased CAR-T cell approvals. Many of them specific stem cell based therapies, as well.
https://www.news-medical.net/whitepaper/20230321/The-promise-of-CAR-T-therapy-in-cancer-treatment.aspx
Cell Therapy News/Articles, page-15600
-
- There are more pages in this discussion • 2,430 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.010(1.01%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| 99.0¢ | $1.03 | 98.5¢ | $1.138M | 1.137M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 42580 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 2173 | 5 |
View Market Depth
| Last trade - 11.31am 05/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |